Gene Expression of Erythropoietin in Renal Cell Carcinoma
スポンサーリンク
概要
- 論文の詳細を見る
- Japanese Society of Internal Medicineの論文
- 1999-12-01
著者
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center Hospital
-
Uike N
National Kyusyu Cancer Center
-
Uike Naokuni
The Department Of Hematology National Kyushu Cancer Center Hospital
-
Uike N
National Hospital Kyushu Cancer Center Fukuoka Jpn
-
Yufu Yuji
The Department Of Hematology National Kyushu Cancer Center Hospital
-
Jimi Atsuo
The Department Of Gastroenterology Cancer Center Hospital
-
NOGUCHI Yumi
the Department of Hematology, National Kyushu Cancer Center Hospital
-
GOTO Tatsuro
the Department of Hematology, National Kyushu Cancer Center Hospital
-
HASEGAWA Yoshihiro
the Department of Urology, National Kyushu Cancer Center Hospital
-
FUKUDA Toshiro
the Department of Pathology, National Kyushu Cancer Center Hospital
-
FUNAKOSHI Akihiro
the First Department of Pathology, Kurume University
-
Funakoshi Akihiro
The First Department Of Pathology Kurume University
-
Noguchi Yumi
The Department Of Hematology National Kyushu Cancer Center Hospital
-
Goto Tatsuro
The Department Of Hematology National Kyushu Cancer Center Hospital
-
Fukuda Toshiro
The Department Of Pathology National Kyushu Cancer Center Hospital
-
Hasegawa Yoshihiro
The Department Of Urology National Kyushu Cancer Center Hospital
関連論文
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Elevated serum levels of human matrix metalloproteinase-9 (MMP-9) during the induction of peripheral blood stem cell mobilization by granulocyte colony-stimulating factor (G-CSF)
- Intensifying Daunorubicin in Induction for Patients with Core Binding Factor Leukemia
- Intensified Daunorubicin in Induction Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Postremission Therapy (Double-7 Protocol) for Adult Acute Myeloid Leukemia
- Severe Aplastic Anemia Associated With Chronic Natural Killer Cell Lymphocytosis
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Early cytomegalovirus (CMV) gastrointestinal disease that developed 19 days after bone marrow transplantation, with a high-level of CMV antigenemia, of up to 1120 cells/slide
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Phase II Study of Cladribine(2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma
- Case-control study of leukemia and diagnostic radiation exposure
- Therapy-Related Leukemia and Myelodysplastic Syndrome: A Large-scale Japanese Study of Clinical and Cytogenetic Features as Well as Prognostic Factors
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- Adult T-Cell Leukemia-Lymphoma Successfully Treated with 2-Chlorodeoxyadenosine
- Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia
- Follicular Dendritic Cell Sarcoma: Ultrastructural and Immunohistochemical Studies
- Lung Injury Associated with Bortezomib Therapy in Relapsed/Refractory Multiple Myeloma in Japan : A Questionnaire-Based Report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical
- Successful Combination Therapy with Trastuzumab and Paclitaxel for Adriamycin- and Docetaxel-Resistant Inflammatory Breast Cancer
- Relationship between morphological classification of the degree of maturation and the ploidy of micromegakaryocytes in myelodysplastic syndrome patients
- Gene Expression of Erythropoietin in Renal Cell Carcinoma
- Carcinoembryonic Antigen-Producing Multiple Myeloma Detected by a Transcription-Reverse Transcription Concerted Reaction System
- Toxicity and Outcome of Intensive Chemotherapy for Acute Lymphoblastic Leukemia Complicated with Turner's Syndrome
- CD2^+ Tetraploid Acute Promyelocytic Leukemia Variant with Double (15 ; 17) Translocations
- Septic Intramuscular Embolism in a Neutropenic Patient with Myelodysplastic Syndrome Accompanied by Asymptomatic Septic Pulmonary Emboli
- Th1/Th2 Lymphocyte Balance in Patients with Aplastic Anemia
- Successful Immunosuppressive Therapy with Cyclosporine A for Posthepatitis B-Cell Deficiency With Activated Cytoplasmic Interferon-γ-Positive T-Lymphocytes
- Renal vein lymphoma embolism in non-Hodgkin lymphoma
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Two Cases of Mediastinal Gray Zone Lymphoma
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies : analysis of eight patients
- Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Gene Expression of Erythropoietin in Hepatocellular Carcinoma.